Cargando…
Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial
OBJECTIVE: Serotonin reuptake inhibitors are frequently used in first-line treatments for patients with obsessive-compulsive disorder. Nevertheless, many of these patients do not respond well to initial therapy. The hypothesis of glutamatergic dysfunction in specific brain regions has been proposed...
Autores principales: | Khalkhali, Mohammadrasoul, Aram, Setareh, Zarrabi, Homa, Kafie, Moosa, Heidarzadeh, Abtin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947218/ https://www.ncbi.nlm.nih.gov/pubmed/27437007 |
Ejemplares similares
-
Lamotrigine Augmentation of Serotonin Reuptake Inhibitors in Severe and Long-Term Treatment-Resistant Obsessive-Compulsive Disorder
por: Arrojo-Romero, Manuel, et al.
Publicado: (2013) -
Efficacy of Transcranial Direct Current Stimulation in the Treatment: Resistant Patients who Suffer from Severe Obsessive-compulsive Disorder
por: Najafi, Kiomars, et al.
Publicado: (2017) -
Metabolic syndrome in patients with obsessive-compulsive disorder
por: Khalkhali, Mohammadrasoul, et al.
Publicado: (2023) -
Cognitive Functioning in Schizophrenia, Methamphetamine-induced Psychotic Disorder, and Healthy People: A Comparative Study
por: Khalkhali, Mohammadrasoul, et al.
Publicado: (2018) -
Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis
por: Sassano-Higgins, Sean A., et al.
Publicado: (2015)